Award Recipients 2019


Michele Umbrello, MD
Department of Anaesthesia and Intensive Care Medicine
Ospedale San Paolo – Polo Universitario, ASST Santi Paolo e Carlo
Milan, Italy


Project: 
Effect of volume EXpansion witH ALbumin vs. crystalloid on EIT-derived expiratory lung impedance in critically ill, hemodynamically unstable patients. A single-blind, randomized and controlled study (the EXHALE study)


Aurora Pujol, MD, PhD
Neurometabolic Diseases Laboratory
Bellvitge Biomedical Research Institute IDIBELL- Hospital Duran i Reynals
Barcelona, Spain

Project: Human albumin in plasma exchange as a novel approach for adrenoleukodystrophy


Award Recipients 2018


Paolo Caraceni, MD
Department of Medical and Surgical Sciences
Alma Mater Studiorum University of Bologna
Bologna, Italy

Project: 
Long‐term albumin administration in patients with decompensated cirrhosis: clinical and pathophysiological implications


Hanadi Sleiman, PhD
Department of Chemistry
McGill University
Montreal, Canada

Project: Albumin as a passive targeting agent: effect of the protein binding on stability, bio distribution and therapeutic outcome of oligonucleotides and DNA nanoparticles


Award Recipients 2017


Anna ROIG, PhD
Institut de Ciència de Materials de Barcelona
Consejo Superior de Investigaciones Científicas
Bellaterra (Barcelona), Spain

Project: 
Albumin-iron oxide nanocages


Karl OETTL, PhD
Institute of Physiological Chemistry
Medical University of Graz
Graz, Austria

Project: Effect of albumin redox state on the intracellular redox balance in cell culture


Award Recipients 2016


Joan CLÀRIA, Bsc, PhD
Hospital Clínic
Faculty of Medicine, University of Barcelona
Barcelona, Spain

Project: 
Effects of native (reduced) and oxidized albumin forms on human leukocyte function


Rudolf E. STAUBER, MD
Division of Gastroenterology and Hepatology
Department of Internal Medicine, Medical University of Graz
Graz, Austria

Project: Effect of albumin infusion on oxidative albumin modification and albumin binding capacity


Award Recipients 2015


Pietro CAIRONI, MD
Department of Pathophysiology and Transplantation
Fondazione IRCCS Ca' Granda – Ospedale Maggiore Policlinico, University of Milan
Milan, Italy

Project: Albumin administration as a therapeutic approach to attenuate sepsis-induced glycocalyx disruption in human septic shock


James RUSSELL, MD
University of British Columbia
Principal Investigator
Centre for Heart Lung Innovation, St. Paul's Hospital
Vancouver, BC, Canada

Project: Is heparin-binding protein a mechanism of Albumin's efficacy in human septic shock?